List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 51 studies with search of:   "Fibrosarcoma"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Surgery and/or Chemotherapy in Treating Children With Infantile, Congenital, or Childhood Fibrosarcoma
Condition: Sarcoma
Interventions: Drug: cyclophosphamide;   Drug: dactinomycin;   Drug: etoposide;   Drug: ifosfamide;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
2 Recruiting Bevacizumab and Radiation Therapy for Sarcomas
Conditions: Soft Tissue Sarcoma;   Fibrous Histiocytoma;   Liposarcoma;   Leiomyosarcoma;   Fibrosarcoma;   Synovial Sarcoma
Interventions: Drug: Bevacizumab;   Procedure: Radiation Therapy
3 Recruiting Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis Cancers
Conditions: Wilms Tumor;   Fibrosarcoma;   Carcinoma, Round Cell;   Nasopharyngeal Cancer;   Brain Tumor, Recurrent
Interventions: Procedure: Myeloablative Chemotherapy;   Procedure: Stem Cell Rescue
4 Recruiting Phase II Study of Sunitinib Malate for Metastatic and/or Surgically Unresectable Soft Tissue Sarcoma
Conditions: Liposarcoma;   Leiomyosarcoma;   Fibrosarcoma
Intervention: Drug: Sunitinib Malate (SUTENT, SU011248)
5 Recruiting Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung
Conditions: Osteosarcoma;   Ewing Sarcoma Family Tumors;   Malignant Fibrous Histiocytoma;   Sarcoma, Synovial;   Fibrosarcoma;   Leiomyosarcoma
Intervention: Biological: REOLYSIN
6 Withdrawn Ifosfamide in Treating Patients With Meningeal Tumors
Conditions: Chondrosarcoma;   Adult Fibrosarcoma;   Adult Leiomyosarcoma;   Adult Rhabdomyosarcoma;   Adult Malignant Meningioma;   Adult Brain Malignant Hemangiopericytoma
Interventions: Drug: ifosfamide;   Procedure: chemotherapy
7 Active, not recruiting Imatinib Mesylate in Treating Patients With Locally Recurrent or Metastatic Dermatofibrosarcoma Protuberans (DFSP) or Transformed Fibrosarcomatous DFSP
Condition: Sarcoma
Intervention: Drug: imatinib mesylate
8 Active, not recruiting Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Dermatofibrosarcoma Protuberans or Giant Cell Fibroblastoma
Condition: Sarcoma
Interventions: Drug: imatinib mesylate;   Procedure: conventional surgery
9 Recruiting A Short Course of Neoadjuvant Gleevec (Imatinib Mesylate) in Dermatofibrosarcoma Protuberans
Condition: Dermatofibrosarcoma Protuberans (DFSP)
Intervention: Drug: Gleevec
10 Recruiting Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes
Conditions: Hypereosinophilic Syndrome;   Systemic Mastocytosis;   Chronic Myelomonocytic Leukemia;   Dermatofibrosarcoma
Intervention: Drug: imatinib mesylate
11 Recruiting Clinical Outcome of Pediatric Dermatofibrosarcoma Protuberans
Condition: Soft Tissue Neoplasms
Intervention:
12 Active, not recruiting Imatinib in Dermatofibrosarcoma Protuberans (DFSP)
Condition: Dermatofibrosarcoma
Intervention: Drug: Imatinib (Glivec)
13 Recruiting Neoadjuvant Imatinib in Dermatofibrosarcoma Protuberans
Condition: Dermatofibrosarcoma Protuberans
Intervention: Drug: imtatinib mesylate
14 Active, not recruiting Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery
Conditions: Childhood Malignant Fibrous Histiocytoma of Bone;   Sarcoma
Interventions: Drug: celecoxib;   Procedure: adjuvant therapy;   Procedure: radiation therapy
15 Recruiting Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
Conditions: Childhood Malignant Fibrous Histiocytoma of Bone;   Sarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Procedure: observation;   Procedure: radiation therapy;   Procedure: therapeutic conventional surgery
16 Recruiting Monoclonal Antibody IMC-A12 and Doxorubicin in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
Conditions: Adult Malignant Fibrous Histiocytoma of Bone;   Sarcoma
Interventions: Drug: cixutumumab;   Drug: doxorubicin hydrochloride
17 Active, not recruiting Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Condition: Tumor
Interventions: Drug: belinostat;   Drug: 5-Fluorouracil (5-FU)
18 Recruiting Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
Conditions: Solid Tumor;   Lymphoma
Intervention: Drug: belinostat
19 Active, not recruiting Combination Chemotherapy in Treating Patients With Advanced Cancer
Conditions: Leukemia;   Lymphoma;   Sarcoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: estramustine phosphate sodium;   Drug: paclitaxel;   Drug: vinorelbine ditartrate
20 Active, not recruiting Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
Conditions: Adrenocortical Carcinoma;   Breast Cancer;   Colorectal Cancer;   Gastrointestinal Cancer;   Kidney Cancer;   Liver Cancer;   Melanoma (Skin);   Ovarian Cancer;   Pancreatic Cancer;   Sarcoma
Interventions: Drug: colloidal gold-bound tumor necrosis factor;   Procedure: conventional surgery;   Procedure: electron microscopy;   Procedure: pharmacological study

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services